DiviDrip · ZURA

ZURA — Zura Bio Limited

ZURA is Zura Bio Limited (Healthcare) — a non-dividend-paying stock. Trading at $6.23. Market cap: $597M. Capital Quality Rank: 83/100 — Elite compounder.

Stock snapshot

Price$6.23
Market cap$597M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)83 / 100 · Elite compounder
Shareholder buyback yield0.00%
Altman Z-score zoneSafe

About ZURA

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Listed2023Employees40HQLa Jolla, CASectorHealthcareWebsitezurabio.com

Related non-dividend companies

Other non-dividend stocks investors research alongside ZURA. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is ZURA's current stock price?

ZURA (Zura Bio Limited) is currently trading at $6.23.

Does ZURA pay a dividend?

ZURA (Zura Bio Limited) does not currently pay a regular dividend.

What is ZURA's Capital Quality Rank?

ZURA has a Capital Quality Rank of 83/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track ZURA in DiviDrip

Add ZURA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-07. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow